KORUST Co., Ltd

What KORUST Co., Ltd does

KORUST Co., Ltd (주식회사 코러스트) is a privately held South Korean medical device manufacturer founded in 2011 and incorporated on 6 February 2012, headquartered in Anyang-si, Gyeonggi-do, with a founder-led management structure under CEO Cho Sung Chan (조성찬). The company develops and commercializes two proprietary technology platforms: High-Intensity Focused Ultrasound (HIFU) for aesthetic, ENT, and consumer-beauty applications, and High-Frequency Chest Wall Oscillation (HFCWO) for respiratory care. Its professional medical portfolio comprises the UTIMS series for skin lifting and body contouring (anchored by the patented CENTERLESS LIFTING technology), CELLEON with Dual Dynamic Ultrasound (DDU), UTIMS CRUISE, UTIMS MINI (the world's first IoT-integrated HIFU device), RHINOS for non-invasive nasal turbinate reduction, and the CAREWAY/TODAK-I hospital respiratory care device. Consumer-facing extensions include BETTRA (home HFCWO) and CELLUPS (home HIFU beauty). KORUST reports it developed Korea's first HFCWO device and is Korea's first company specialized in HIFU since 2012, claiming over 50% domestic market share for CAREWAY in Korean hospitals.

The go-to-market model is dual-channel: direct enterprise sales to Korean hospitals and university medical centers (with named installations at Seoul National University Hospital, Samsung Medical Center, and numerous regional university hospitals including Wonkwang, Catholic University Daejeon St. Mary's, Kangwon National, Soonchunhyang, Gachon University Gil, Eulji, Dankook, Chung-Ang, Chonnam, and Korea University Anam), complemented by a distributor-led export model reaching approximately 45 countries with documented multi-year presence in Saudi Arabian national hospitals, plus direct-to-consumer sales of home devices via a directly-managed Gangnam showroom (opened 2022) and product-specific e-commerce sites. Lead generation depends heavily on international exhibitions including MEDICA (Germany), WHX Dubai/Arab Health, AMWC Monaco, KIMES Korea, COSME WEEK Tokyo, COSMOPROF ASEAN, and Vietbeauty. Revenue is generated principally through one-time hardware sales of professional devices, with supplementary consumer-hardware and after-sales service revenue; no pricing is publicly disclosed.

The company holds multiple granted patents (CENTERLESS LIFTING, DDU, Concave Piezoelectric Ceramic Impedance Matching, ALFUS, HFCWO) and a dense regulatory stack including ISO 13485:2016, CE MDD, KFDA product approvals (notably RHINOS in 2025), TFDA, SFDA, and GCC certifications, together with the 2025 MOTIE/KOTRA World-Class Product designation for CAREWAY and the MEDICA 2025 World's Best Product Award. With only six disclosed employees, operations are notably lean for a 45-country exporter, and KORUST remains entirely private with no recorded institutional or venture capital investment.

Name

KORUST Co., Ltd

Legal name

KORUST Co., Ltd

Website

https://korust.com

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

1–10 employees

Short description

KORUST Co., Ltd is a South Korean privately-held medical device manufacturer specializing in High-Intensity Focused Ultrasound (HIFU) and High-Frequency Chest Wall Oscillation (HFCWO) technologies, serving hospitals, aesthetic clinics, and consumers across approximately 45 countries.

Ownership category

akta.pro rank

Product category

Medical Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro industry

PRIMARYHLAHAGAE

Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories)

Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

SECONDARYCRADAMAK

Personal Medical Devices & Home Diagnostics (Thermometers, Blood Pressure Monitors, Glucose Meters, Rapid Tests)

Consumer Products & Retail/Consumer Packaged Goods (CPG) Manufacturing & Brands/Health & Hygiene OTC Consumer Goods (First Aid, Oral Care, Personal Health)

Keywords

• HIFU medical devices
• HFCWO respiratory therapy
• Aesthetic ultrasound equipment
• Chest wall oscillation devices
• Medical device manufacturing

Headquarters

HQ city

Anyang-si

HQ country

South Korea

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Medical Device Sales (Professional): Sales of professional-grade medical devices to hospitals and clinics, including UTIMS HIFU systems for aesthetic treatments, CAREWAY/TODAK-I for respiratory care, and RHINOS for ENT treatment. Revenue is generated through one-time device sales with potential after-sales service and consumables.
2. Home Care Device Sales: Sales of consumer-grade home care devices including BETTRA (home HFCWO) and CELLUPS (home HIFU beauty device) through direct sales, showrooms, and e-commerce channels.
3. Export/International Sales: Revenue from exports to 45 countries worldwide, including Middle East, Europe, Southeast Asia, Taiwan, and other regions through distributor networks.

Go-to-market motion3 records

Distribution channels5 records

Marketing channels5 records

Core offering

KORUST Co., Ltd develops, manufactures, and commercializes medical devices built on two proprietary technology platforms: High-Intensity Focused Ultrasound (HIFU) and High-Frequency Chest Wall Oscillation (HFCWO). Its product portfolio includes professional hospital-grade devices for respiratory care (CAREWAY/Todak-i), non-invasive aesthetic treatments (UTIMS A3, CELLEON, CRUISE, UTIMS MINI), and ENT treatment (RHINOS), as well as consumer home-care products (BETTRA, CELLUPS).

Product overview

KORUST Co., Ltd operates as a medical device manufacturer specializing in two core technology platforms: High Frequency Chest Wall Oscillation (HFCWO) devices for respiratory care and High Intensity Focused Ultrasound (HIFU) devices for aesthetic and medical applications. The HFCWO portfolio includes CAREWAY/토닥이 (hospital-use) and BETTRA (home-use), both developed with proprietary patented technology. The HIFU portfolio includes the UTIMS series (A3, CRUISE, mini) featuring CENTERLESS LIFTING technology, CELLEON with dual-frequency ultrasound, RHINOS for ENT applications, and CELLUPS for home-use beauty aesthetics. The company exports to 45 countries worldwide and maintains ISO 13485 certification.

Differentiator

Problem solved

Functional benefit

Brands

• BETTRA (베트라): Home-use high-frequency chest wall oscillation (HFCWO) device for lung secretion clearance. Operated at bettra.co.kr.
• CAREWAY / 토닥이
• UTIMS A3 / 뉴테라
• CELLEON (셀레온)
• UTIMS CRUISE (크루즈)
• UTIMS MINI (미니)
• RHINOS (라이노스)
• CELLUPS (셀럽스)

Products and services

• BETTRA (베트라) Home-care high-frequency chest wall oscillator (HFCWO) medical device developed with patented technology to clear lung secretions including fine dust, mucus, and sputum. Uses up to 20Hz vibration frequency to separate and expel pulmonary deposits. Sold to individual consumers via e-commerce and showroom.
• CAREWAY / 토닥이 (Todak-i) Hospital-use high-frequency chest wall oscillator (HFCWO) for chest physiotherapy to aid patients with lung secretion clearance. Achieved over 50% domestic market share in Korean hospitals. A battery-powered version launched in 2023 offering 120 minutes of use per full charge.
• UTIMS A3 / 뉴테라 (Newtera) High-intensity focused ultrasound (HIFU) device featuring CENTERLESS LIFTING patented technology that minimizes pain and skin burns while maximizing lifting effectiveness. Used by aesthetic and medical beauty clinics for face lifting and body contouring.
• CELLEON (셀레온) World's first medical aesthetic device with dual frequency and 10MHz nano ultrasound energy, applying DDU (DUAL DYNAMIC ULTRASOUND) technology for simultaneous high and low frequency irradiation to achieve skin rejuvenation and body tightening.
• UTIMS CRUISE (크루즈) HIFU device combining DDU (DUAL DYNAMIC ULTRASOUND) technology with high-intensity focused ultrasound in a single platform for comprehensive aesthetic treatments. Features CENTERLESS LIFTING technology.
• UTIMS MINI (미니) Compact and portable HIFU device employing IoT technology for real-time online management. Features CENTERLESS lifting technology with up to 97% of original UTIMS performance. World's first IoT-integrated HIFU device.
• RHINOS (라이노스) Non-invasive HIFU-based medical device for inferior turbinate reduction. Uses focused ultrasound energy to treat nasal airway obstruction without anesthesia, bleeding, or thermal damage. Targets ENT departments.
• CELLUPS (셀럽스) Premium home-care beauty device utilizing ALFUS (Acoustic Lens multi-Focused Ultra Sound) technology derived from professional UTIMS aesthetic systems. Delivers clinic-level HIFU performance safely for home use with multi-focus energy delivery without coupling medium.

Quantifiable outcome

• Domestic hospital market share exceeding approximately 50% for CAREWAY respiratory care device
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature7 records

Scale indicators6 records

Recent moves12 records

Expansion highlights6 records

Direct peers

• Classys Inc. KOSDAQ-listed Korean maker of the Ultraformer HIFU aesthetic platform — the most direct domestic competitor to KORUST's UTIMS line, serving the same dermatology and medical-spa clinic channel with overlapping distributor networks across Asia, the Middle East, and Latin America.
• Jeisys Medical: KOSDAQ-listed Korean HIFU and RF aesthetic device maker (ULTRAFORMER, INTRAcel) — competes head-on with KORUST's UTIMS A3 and CELLEON systems in Korean and export clinics, with comparable regulatory coverage (KFDA, CE, FDA).
• Hironic Co., Ltd. KOSDAQ-listed Korean HIFU manufacturer of the Doublo series — directly competes with KORUST in HIFU skin-lifting and body-contouring, particularly across Asian and Middle Eastern aesthetic clinic channels.
• Monaghan Medical: Trudell Medical subsidiary behind the Aerobika airway-clearance device — competes with CAREWAY/TODAK-i in the same hospital and home respiratory-care markets across North America and Europe.
• Electromed, Inc. U.S. manufacturer of the SmartVest HFCWO airway-clearance system — the closest international peer to KORUST's CAREWAY/Todak-i and BETTRA, sharing the HFCWO mechanism, target patient population, and reimbursement-driven hospital sales motion.
• Merz Aesthetics (Ulthera): Global category leader in HIFU aesthetics via the Ultherapy platform — the international benchmark against which UTIMS and CELLUPS compete, with deep regulatory footprints (FDA, CE) and a global physician training infrastructure KORUST would need to match.

Emerging players

• Sofwave Medical: Public emerging player with a non-invasive ultrasound-based aesthetic platform positioned between HIFU and RF — partial overlap with KORUST's UTIMS and CELLUPS offerings, particularly in dermatology and home-use aesthetics.
• InSightec Ltd. Israeli developer of MR-guided focused ultrasound (ExAblate) for tremor, prostate and oncology — a peer on the underlying HIFU/ultrasound technology axis KORUST has built around, but operating in medical rather than aesthetic indications.

Broad incumbents

• Cynosure: Global aesthetic device incumbent with HIFU (SculpSure/legacy), RF and laser systems — competes with KORUST in dermatology and medical-spa accounts at the platform-portfolio level rather than in HIFU alone.
• InMode Ltd. NASDAQ-listed global aesthetic device incumbent with a broad energy-based portfolio (RF, IPL, Morpheus8) — indirect competitor to UTIMS/CELLEON in the same clinical accounts but a much larger installed base and capital base.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@ulinkworldkorust293
• Facebookfacebook.com/UTIMS0206
• LinkedInlinkedin.com/company/korust-co-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about KORUST Co., Ltd